beta

SWKHL

Swk Holdings Corp

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

swk holdings corporation is focused on becoming a market leading innovator in healthcare finance by providing capital to a broad range of life science companies, institutions and inventors. swk’s primary focus is on monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. the company believes its financing structures achieve an optimal partnership for companies, institutions and inventors seeking capital for expansion or capital and estate planning by allowing its partners to monetize future cash flow with minimal dilution to their equity stakes. swk funds transactions through its balance sheet as well as through its registered investment advisory subsidiary.

Market Cap: 203 Million

Primary Exchange: NASDAQ

Website: swkhold.com

Shares Outstanding: 12.5 Million

Float: 0

Dividend: 0.543749988079071 (0.02%)

Beta: -0.007769673702469802

Sector: Finance and Insurance

Industry: International Trade Financing

Ethical Flags

Longest drawdown: 46 trading days

From: 2023-12-08 To: 2024-02-22

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
2023-12-14 2023-12-31 2023-12-15 0.5371 Cash
2024-03-14 2024-03-31 2024-03-15 0.5625 Cash
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud